Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.
A research team at Marburg University has investigated one of the largest enzyme complexes found in nature to date and ...
Interesting Engineering on MSN
Simple molecular tweak reveals how to control excitons in 2D perovskites
Two-dimensional perovskites are often seen as leading candidates for future LEDs and solar cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results